Isoprostanes: an overview and putative roles in pulmonary pathophysiology
LJ Janssen - American Journal of Physiology-Lung Cellular …, 2001 - journals.physiology.org
Isoprostanes are produced during peroxidation of membrane lipids by free radicals and
reactive oxygen species. Initially, they were recognized as being valuable markers of …
reactive oxygen species. Initially, they were recognized as being valuable markers of …
Vascular biology of the isoprostanes
JL Cracowski, P Devillier, T Durand… - Journal of vascular …, 2001 - karger.com
Isoprostanes are a family of compounds produced from polyunsaturated fatty acids via a free-
radical-catalysed mechanism. F2-isoprostanes are prostaglandin F2α isomers derived from …
radical-catalysed mechanism. F2-isoprostanes are prostaglandin F2α isomers derived from …
Smoking-induced vascular disease: a new twist on an old theme
P McNamara, GA FitzGerald - Circulation Research, 2001 - Am Heart Assoc
Polycyclic aromatic hydrocarbons (PAHs) are recog-nized widely as potential environmental
procarcinogens and have attracted their share of attention from both funding agencies and …
procarcinogens and have attracted their share of attention from both funding agencies and …
ANTICOGULATE OR NOT TO ANTICOGULATE PATIENTS WITH CARDIOMYOPATHY
SP Graham - Cardiology clinics, 2001 - cardiology.theclinics.com
Cavdiomyopathy, a disorder of the myocardial tissue, is an entity of increasing incidence
and pre~ alence.~~ The commonest causes of congestive heart failure (CHF) are large …
and pre~ alence.~~ The commonest causes of congestive heart failure (CHF) are large …
[PDF][PDF] Oxidized lipids
P Patrignani - ITALIAN HEART JOURNAL, 2001 - ifcardio.org
Arachidonic acid, a polyunsaturated fatty acid containing 4 cis double bonds esterified at the
sn-2 position of the glycerol backbone of membrane phospholipids, once released by the …
sn-2 position of the glycerol backbone of membrane phospholipids, once released by the …
[PDF][PDF] The Aspirin as a Protective Factor During Hospital Evolution of the Acute Ischemic Syndrome Without Persistent ST-Segment Elevation
JO Bono, G Fernández Cid, H Ramos - benefits - fac.org.ar
Introduction: According to world literature published, the risk of patients with Acute Ischemic
Syndromes (AIS) without persistent ST-segment elevation who were taking aspirin (AAS) …
Syndromes (AIS) without persistent ST-segment elevation who were taking aspirin (AAS) …
[引用][C] What are the current issues regarding aspirin and other cyclooxygenase inhibitors?
C Patrono - Chest, 2001